Prochirurgija - Company finances
|
EUR
|
2018
From: 2018-03-22
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 2,350 | 11,390 | 16,020 | 15,291 | 17,620 | 18,000 | 17,250 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -13,381 | -27,971 | -21,026 | -28,405 | -14,606 | -10,684 | -11,098 | -6,645 |
| Equity | -10,881 | -38,852 | -59,878 | -88,283 | -102,858 | -113,542 | -124,640 | -131,285 |
| Liabilities | 20,379 | 95,989 | 103,885 | 111,109 | 118,004 | 122,761 | 127,766 | 134,105 |
| Non-current assets | 0 | 33,609 | 27,338 | 20,602 | 13,721 | 7,321 | 1,565 | 388 |
| Current assets | 9,498 | 5,199 | 2,092 | 2,224 | 1,425 | 1,898 | 1,561 | 2,432 |
| Total assets | 9,498 | 38,808 | 29,430 | 22,826 | 15,146 | 9,219 | 3,126 | 2,820 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,799 | 2,097 | 1,942 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +384.7% | +40.6% | -4.6% | +15.2% | +2.2% | -4.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -140.9% | -72.1% | -71.4% | -124.4% | -96.4% | -115.9% | -355.0% | -235.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -1190.3% | -184.6% | -177.3% | -95.5% | -60.6% | -61.7% | -38.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 1,880 | 5,695 | 6,629 | 5,397 | 8,810 | 9,000 | 8,625 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Prochirurgija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-16 | 2026-08-16 | 0.13 |
| 2026-07-28 | 2026-08-14 | 0.13 |
| 2026-07-23 | 2026-07-26 | 0.13 |
| 2026-07-19 | 2026-07-19 | 111.17 |
| 2026-07-16 | 2026-07-17 | 111.17 |
| 2026-05-17 | 2026-05-17 | 121.02 |
| 2026-01-21 | 2026-02-16 | 0.31 |
| 2025-12-16 | 2025-12-21 | 166.44 |
| 2025-10-23 | 2025-11-13 | 0.13 |
| 2025-09-16 | 2025-09-17 | 171.61 |
| 2025-02-18 | 2025-02-20 | 183.89 |
| 2025-01-22 | 2025-02-17 | 0.33 |
| 2024-11-19 | 2024-11-25 | 11.59 |
| 2024-11-18 | 2024-11-18 | 190.13 |
| 2024-10-24 | 2024-11-17 | 0.26 |
| 2024-10-16 | 2024-10-16 | 179.41 |
| 2024-09-17 | 2024-09-18 | 159.10 |
| 2024-08-19 | 2024-08-21 | 14.81 |
| 2024-07-16 | 2024-07-16 | 157.36 |
| 2023-08-17 | 2023-08-20 | 140.86 |
| 2023-07-24 | 2023-08-16 | 0.05 |
| 2023-06-16 | 2023-07-10 | 0.26 |
| 2023-05-02 | 2023-05-10 | 0.26 |
| 2023-04-25 | 2023-04-28 | 0.26 |
| 2023-02-21 | 2023-03-06 | 0.05 |
| 2023-02-17 | 2023-02-20 | 173.19 |
| 2023-02-06 | 2023-02-16 | 0.05 |
| 2023-01-23 | 2023-02-03 | 0.05 |
| 2022-11-21 | 2022-12-14 | 0.07 |
| 2022-11-17 | 2022-11-18 | 0.07 |
| 2022-10-28 | 2022-11-13 | 0.07 |
| 2022-09-19 | 2022-09-25 | 9.85 |
| 2022-09-16 | 2022-09-18 | 169.05 |
| 2022-06-16 | 2022-06-16 | 172.94 |
| 2022-03-16 | 2022-03-17 | 120.79 |
Prochirurgija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-31 | 2025-09-03 | 0.04 |
| 2024-12-17 | 2024-12-30 | 0.2 |
| 2024-11-17 | 2024-11-18 | 40.45 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Prochirurgija, UAB (code 304805922) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of EUR 17.2K and recorded a net loss of EUR 6.6K, resulting in a negative profit margin of 38.5%. Revenue remained broadly stable over the last three years, moving from EUR 17.6K in 2023 to EUR 18.0K in 2024 and EUR 17.2K in 2025, while losses narrowed in 2025 compared with EUR 10.7K in 2023 and EUR 11.1K in 2024. The balance sheet remained small: total assets stood at EUR 2.8K in 2025, down from EUR 3.1K in 2024 and EUR 9.2K in 2023. Equity was negative at EUR 131.3K, while liabilities increased to EUR 134.1K. Asset turnover was 6.12x in 2025, indicating revenue generation from a limited asset base. Revenue per employee was EUR 8.6K, and profit per employee was negative at EUR 3.3K, reflecting continued operating losses.